1. Aide
    1. Espace Client
    2. Connexion
  1. Aide
    1. Espace Client
    2. Connexion
Espace Membre Boursorama

Erreur d'authentification

Vous êtes authentifié. Nous chargeons votre espace membre.

Mot de passe oublié ?

Nouveau sur Boursorama ? Devenez membre

Identifiant/Mot de passe oublié
Si vous êtes Membre de la Communauté Boursorama, veuillez indiquer l'adresse email que vous avez fournie lors de votre enregistrement pour recevoir votre identifiant et/ou ré-initialiser votre mot de passe :

Nouveau sur Boursorama ? Devenez membre

Fermer

MEDTECH : MEDTECH FOUNDER AND CEO BERTIN NAHUM APPOINTED MEMBER OF THE FRENCH NATIONAL DIGITAL COUNCIL (CNN*)
Actusnews10/02/2016 à 18:00

Montpellier, France, February 9, 2016 - MEDTECH (Euronext, FR0010892950 - ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, has announced the appointment of CEO and Founder Bertin Nahum to the French National Digital Council (CNN*).
 

Bertin Nahum was delighted to be appointed as a member of CNN. The French National Digital Council is an institution which is independent from the Government and whose mission is to formulate opinions on any question relative to the impact of digital technology on society and the economy. CNN was formed by Emmanuel Macron, Minister of the Economy, Industry and Digital Technology, and Axelle Lemaire, State Secretary for Digital technology, in April 2011.
 

"This appointment is a personal honor, and I am very proud to be part of the French National Digital Council," said Bertin Nahum, CEO and Founder of Medtech. "As a member, I shall be committed to the missions of this institution which is essential in a world of digital transitions. It will be a pleasure for me to work alongside the Council's renowned members led by the new President, Mounir Mahjoubi."
 

*Conseil National du Numérique.

 

About MEDTECH
 
Founded in 2002 by Bertin NAHUM and based in Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.
In 2007, MEDTECH developed ROSA(TM), an innovative technological device devoted to brain surgery procedures. ROSA(TM) has been approved in Europe, the United States and Canada.
In 2013 MEDTECH received the "European Company of the Year Award" in the "robotic neurosurgery" category from Frost & Sullivan.
In July 2014, MEDTECH obtained the CE marking for its new product ROSA(TM) Spine, a robotic- assistive device for minimally invasive surgery of the spine.
In October 2014, MEDTECH won the "Révélation" prize in the Mediterranean Deloitte Technology Fast 50 Awards.
In 2015 MEDTECH received the "2016 Company of the Year Award" in the "robotic neurosurgery" category from Frost & Sullivan.
In November 2015, MEDTECH was honored by Deloitte In Extenso for its excellent performance in the Technology Fast 50 Mediterranean Awards, in the "listed company" category.
In January 2016, MEDTECH obtained the FDA clearance for its new product, ROSA(TM) Spine, a robotic-assistive device for minimally invasive surgery of the spine.

 
CONTACT MEDTECH
Christophe Sibillin
Chief Financial Officer
Tel : +33 (0)4 67 10 77 40
INVESTORS
Corinne Puissant
Tel : +33 (0)1 53 67 36 77
cpuissant@actus.fr
PRESS
Alexandra Prisa (EU) Joanna Zimmerman (US)
Tel. : +33(0)1 53 67 36 90 Tel : +1 646-536-7006
aprisa@actus.fr jzimmerman@theruthgroup.com

Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués
Full and original press release in PDF:
http://www.actusnews.com/documents_communiques/ACTUS-0-43072-UK_CNN-Bertin-Nahum_VDEF.pdf

Valeurs associées

Euronext Paris 0.00%

0 commentaire

Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement

Signaler le commentaire

Fermer

Mes listes

Une erreur est survenue pendant le chargement de la liste

valeur

dernier

var.

Les Risques en Bourse

Fermer